Maps the tumor microenvironment through single cell and imaging analysis to show how a cancer is built.
Consented intake · your records travel with you · nothing moves without your sign-off
Reveal provides spatial analysis of tumor tissue, using techniques such as single cell analysis, flow cytometry, CODEX multiplex imaging, and immunohistochemistry staining. The aim is to map the tumor microenvironment, especially cancer heterogeneity and immune cell proliferation, information that can deepen a patient's understanding of their disease.
Prefer the source? Reveal's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Reveal handles billing.
We don't have confirmed insurance details for Reveal yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Reveal's details here. Educational only; your oncologist directs treatment.
Ask OpenCancer · answers grounded in this storefront
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.